Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03029260
Other study ID # NSM01
Secondary ID
Status Completed
Phase N/A
First received January 19, 2017
Last updated April 4, 2018
Start date January 2017
Est. completion date December 2017

Study information

Verified date April 2018
Source Aveiro University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to compare the effect of tension neural mobilization versus sliding neural mobilization of the peroneal nerve on the heat and cold threshold, on pressure pain threshold and on flexibility both in the dominant lower limb (subjected to mobilization) and the non-dominant lower limb (not subjected to mobilization) in healthy young participants.


Description:

Sixty young and healthy participants will be randomly allocated to receive tension neural mobilization (n=30) or sliding neural mobilization (n=30). Data on heat threshold, cold threshold, pressure pain threshold and lower limb flexibility will be collected before the intervention, immediately after the intervention and at least 24h after the intervention.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date December 2017
Est. primary completion date July 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- naïve to nervous system mobilization;

Exclusion Criteria:

- Any surgery or trauma in the previous 6 months; neurological, cardiorespiratory or rheumatic pathology; cancer.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Neural mobilization - tension.
Neural mobilization in tension consists of using combinations of joint movement known to maximize the tension and lengthening of peripheral nervous structures. The intervention will be delivered in one session only.
Neural mobilization - gliding
Gliding neural mobilization consists of using combinations of joint movement known to maximize the movement of the peripheral nerves in relation to adjacent structures. The intervention will be delivered in one session only.

Locations

Country Name City State
Portugal School of Health Sciences Aveiro

Sponsors (1)

Lead Sponsor Collaborator
Aveiro University

Country where clinical trial is conducted

Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Range of motion of the Straight Leg Raising test The hip is raised to maximum flexion and the degree of flexion is measured with universal goniometer Baseline
Primary Range of motion of the Straight Leg Raising test The hip is raised to maximum flexion and the degree of flexion is measured with universal goniometer Approximately 45 minutes after baseline measurements
Primary Range of motion of the Straight Leg Raising test The hip is raised to maximum flexion and the degree of flexion is measured with universal goniometer At least 24 hours after baseline measurements
Secondary Heat threshold This is measured with a QSense instrument, which has thermode that is attached to the skin. The temperature in this thermode increases or decreases (as per the protocol being used) and the participants is holding a device to stop the temperature to increase/decrease when he/she first perceives it. The temperature perceived is the test result. Baseline
Secondary Heat threshold This is measured with a QSense instrument, which has thermode that is attached to the skin. The temperature in this thermode increases or decreases (as per the protocol being used) and the participants is holding a device to stop the temperature to increase/decrease when he/she first perceives it. The temperature perceived is the test result. Approximately 45 minutes after baseline measurements
Secondary Heat threshold This is measured with a QSense instrument, which has thermode that is attached to the skin. The temperature in this thermode increases or decreases (as per the protocol being used) and the participants is holding a device to stop the temperature to increase/decrease when he/she first perceives it. The temperature perceived is the test result. At least 24 hours after baseline measurements
Secondary Cold threshold This is measured with a QSense instrument, which has thermode that is attached to the skin. The temperature in this thermode increases or decreases (as per the protocol being used) and the participants is holding a device to stop the temperature to increase/decrease when he/she first perceives it. The temperature perceived is the test result. Baseline
Secondary Cold threshold This is measured with a QSense instrument, which has thermode that is attached to the skin. The temperature in this thermode increases or decreases (as per the protocol being used) and the participants is holding a device to stop the temperature to increase/decrease when he/she first perceives it. The temperature perceived is the test result. Approximately 45 minutes after baseline measurements
Secondary Cold threshold This is measured with a QSense instrument, which has thermode that is attached to the skin. The temperature in this thermode increases or decreases (as per the protocol being used) and the participants is holding a device to stop the temperature to increase/decrease when he/she first perceives it. The temperature perceived is the test result. At least 24 hours after baseline measurements
Secondary Pressure pain threshold This is measured using a pressure pain algometer. Pressure is made with this device against a specific body region (upper and lateral part of the dominant foot) until the participants perceives that the pressure changes to pain. The amount of pressure that the participants perceives as being painful is the test result. Baseline
Secondary Pressure pain threshold This is measured using a pressure pain algometer. Pressure is made with this device against a specific body region (upper and lateral part of the dominant foot) until the participants perceives that the pressure changes to pain. The amount of pressure that the participants perceives as being painful is the test result. Approximately 45 minutes after baseline measurements
Secondary Pressure pain threshold This is measured using a pressure pain algometer. Pressure is made with this device against a specific body region (upper and lateral part of the dominant foot) until the participants perceives that the pressure changes to pain. The amount of pressure that the participants perceives as being painful is the test result. At least 24 hours after baseline measurements
See also
  Status Clinical Trial Phase
Completed NCT06044896 - Physiology of Body Lateralization on Regional Lung Ventilation Study N/A
Completed NCT02101801 - Urine Drug Levels Related to Source of Water for Irrigation for Vegetable Crops Among Healthy Israeli Volunteers N/A
Recruiting NCT06101641 - Effect of Shellac Nail Polish Application on Pulse Oximetry Measurements in Healthy Individuals N/A
Completed NCT03065283 - Effects of Diaphragm-releasing Techniques on the Lumbar Spine and Diaphragmatic Function in Healthy Women N/A
Recruiting NCT01721811 - Retinal Function in Relation to Transient or Chronic Challenges to Retinal Metabolism N/A
Completed NCT01211717 - The Effects of Orally Ingesting Branched Chained Amino Acids on Delayed Onset Muscle Soreness in Diabetic Patients N/A
Completed NCT01568541 - Fluoride Intake From Toothbrushig With Children's or Regular Toothpastes N/A
Completed NCT04941196 - Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting Condition Phase 1
Completed NCT05541094 - Study of Vitamin D Fortification of Milk and Oil
Completed NCT05597657 - Normal Variation of T1 Values With Cardiac Magnetic Resonance in Healthy Individuals N/A
Completed NCT03728868 - Tolerability and Risk of Adverse Events With a Probiotic Supplement N/A
Recruiting NCT04513782 - The Contributions of Age Related Changes in the Sound Localization Pathway to Central Hearing Loss
Completed NCT05637060 - Bioequivalence Study of Rosuvastatin Tablet N/A
Not yet recruiting NCT05110885 - Public AttitudesTowards SMA and DMD Awareness, Newborn and Carrier Screening and Physiotherapy Practices
Completed NCT01134978 - Neural Mechanisms of the Contextual Interference Effect: A fNIRs and EEG Study Phase 1
Completed NCT06137534 - Upper Extremity Pattern Exercises and Respiratory Functions N/A
Completed NCT04873570 - Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects Phase 1
Enrolling by invitation NCT01872091 - Analysis of Neuromuscular, Circulatory and Biomechanical Responses After Cryotherapy N/A
Completed NCT01872117 - Assessment of Temperature by Infrared Thermography and Blood Conduction Velocity by Doppler After Applying Shortwave Diathermy and Microwave - Correlations With Cardiovascular and Hemodynamic Parameters N/A
Completed NCT02409836 - A Study to Assess the Ingestion of Dentifrice by Children N/A